N-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-acetamide, 98%, 100mg

1,3-Bis(3-carboxypropyl)tetramethyldisiloxane, 95%, 5g

(4-tert-Butylphenyl)glyoxylic acid, 97.0%, 5g

3-(1,2,3-Thiadiazol-4-yl)phenol, 97%, 250mg

tert-Butyl 8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinoline-2(1H)-carboxylate, 97%, 250mg

HWF 10x/20 mm eyepiece with 10/100 micrometer and reticle for bScope for Ø 23.2 mm tube

5-FLUOROPYRIMIDINE-2-CARBALDEHYDE, 95.0%, 1g

Benzyl 4-(2-(tert-butoxycarbonyl)hydrazinyl)piperidine-1-carboxylate, 95.0%, 1g

C-Isoxazol-5-ylmethanamine hydrochloride, 95.0%, 1g

8-chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine, 99.00%, 10g

6-BROMO-3-(PIPERIDIN-1-YLMETHYL)-1H-INDOLE, 95.0%, 250mg

3-Fluoro-2-methylanisole, 95.0%, 5g

Reversible frit 50 ml, 3 (16 – 40 μm), 1 Piece